Added to YB: 2026-01-22
Pitch date: 2026-01-20
ALAFY.PA [bullish]
AFYREN SAS
-9.51%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids.
Market Cap
EUR 74.7M
Pitch Price
EUR 3.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.89
P/E
-6.50
EV/Sales
18.41
Sector
Chemicals
Category
growth
AFYREN (ALAFY France): from proof of concept to industrial reality as Neoxy clears a key hurdle
ALAFY.PA (update): Industrial biotech proved tech works at scale w/ Neoxy plant producing 400 tonnes bio-acids in 2025, €1M revenue. Secured €165M contract base across 10 customers, new F&F tender won for 2026. Targeting several-thousand-tonne production 2026. €35M cash provides execution runway. De-risked from binary 'does-it-work' to scalability story.
Read full article (2 min)